|
Market Closed -
Euronext Paris
11:55:00 2026-09-10 am EDT
|
5-day change | 1st Jan Change | ||
| 26.20 EUR | +0.38% |
|
+2.34% | -13.53% |
| Apr. 22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Apr. 05 | Boiron SA announces Annual dividend, payable on June 05, 2026 | CI |
| Market Cap | 455M 529M 429M 391M 731M 50.57B 738M 5.11B 1.97B 25.65B 1.99B 1.94B 81.47B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 407M 473M 384M 350M 654M 45.25B 660M 4.57B 1.76B 22.95B 1.78B 1.74B 72.9B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BOI | Real-time | |
OTC Markets
| BOIRF | Delayed | |
|
CBOE
| BOIp | Real-time | |
|
Börse Stuttgart
| BON | Delayed | |
|
Deutsche Boerse AG
| BON | Delayed | |
|
CBOE
| 0DTF | Real-time | |
|
Boerse Muenchen
| BON | Real-time |
| 1 day | +0.38% | ||
| 1 week | +2.34% | ||
| Current month | +2.75% | ||
| 1 month | -0.38% | ||
| 3 months | -8.39% | ||
| 6 months | -2.06% | ||
| Current year | -13.53% |
| 1 week | 26 |  | 26.7 |
| 1 month | 25 | | 26.7 |
| Current year | 24.35 | | 30.95 |
| 1 year | 23.45 | | 32.25 |
| 3 years | 20.85 | | 56.5 |
| 5 years | 20.85 | | 56.5 |
| 10 years | 20.85 | | 92.91 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 2024-12-31 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 2011-06-30 |
| Director/Board Member | 54 | 2010-03-09 | |
| Director/Board Member | 51 | 2013-05-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/29/23 | Sell | Director | 198,664 | 1.1323% | ||
| 10/29/23 | Sell | Director | 462,964 | 2.6387% | ||
| 10/29/23 | Sell | Director | 4,748 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.38% | +2.34% | +9.85% | -51.03% | 529M | |
| -0.14% | -0.73% | -15.19% | -4.85% | 13.4B | |
| -1.21% | -0.67% | -32.65% | -56.66% | 4.84B | |
| -1.26% | -3.05% | -5.72% | -5.01% | 4.39B | |
| -1.78% | -1.91% | -11.02% | -29.81% | 3.84B | |
| -0.97% | -0.08% | -1.62% | +0.47% | 3.5B | |
| -0.62% | -2.70% | -24.06% | +4.95% | 3.47B | |
| -1.74% | -3.68% | -12.93% | +5.44% | 3.15B | |
| -0.88% | -1.35% | -22.94% | -15.17% | 2.3B | |
| -1.10% | -0.90% | -29.45% | -15.19% | 1.67B | |
| Average | -0.93% | -1.81% | -14.57% | -16.69% | 4.11B | |
| Weighted average by Cap. | -0.85% | -2.09% | -15.96% | -12.83% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 567M 460M 419M 783M 54.2B 791M 5.48B 2.11B 27.49B 2.13B 2.08B 87.32B | 501M 583M 473M 431M 805M 55.71B 812M 5.63B 2.17B 28.26B 2.19B 2.14B 89.75B |
| Net income | 11.34M 13.18M 10.7M 9.74M 18.21M 1.26B 18.38M 127M 49.03M 639M 49.5M 48.42M 2.03B | 32.64M 37.96M 30.8M 28.06M 52.45M 3.63B 52.93M 367M 141M 1.84B 143M 139M 5.85B |
| Net Debt | -49.74M -57.83M -46.93M -42.75M -79.92M -5.53B -80.64M -559M -215M -2.8B -217M -212M -8.91B | -47.86M -55.65M -45.15M -41.13M -76.89M -5.32B -77.59M -538M -207M -2.7B -209M -204M -8.57B |
Employees
2,499
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | €26.20 | +0.38% | 886 |
| 26-09-09 | €26.10 | -1.14% | 905 |
| 26-09-08 | €26.40 | +0.38% | 549 |
| 26-09-07 | €26.30 | +1.15% | 2,194 |
| 26-09-04 | €26.00 | +1.56% | 1,850 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
Select your edition
All financial news and data tailored to specific country editions
